Completed PHASE4 INTERVENTIONAL 2-arm NCT03283813

ZIMBA: Clinical Trial in Paediatric Obesity (ZIMBA)

Effects of a Supplementation With Zinc and Myo-inositol in Paediatric Obesity

Sponsor: Azienda Ospedaliero Universitaria Maggiore della Carita

Conditions Inositol Insulin Resistance Obesity, Childhood Zinc Deficiency

Updated 9 times since 2017 Last updated: Aug 8, 2024 Started: Feb 5, 2018 Primary completion: Dec 31, 2023 Completion: Mar 10, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Inositol and Insulin Resistance, this trial is completed. The trial is conducted by Azienda Ospedaliero Universitaria Maggiore della Carita and has accumulated 9 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4

Status: Recruiting → Completed
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
Apr 2022 — Jul 2024 [monthly]

Recruiting PHASE4

Status: Unknown Status → Recruiting
Oct 2021 — Apr 2022 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Recruiting PHASE4

▶ Show 4 earlier versions

Aug 2019 — Jan 2021 [monthly]

Recruiting PHASE4
Jun 2018 — Aug 2019 [monthly]

Recruiting PHASE4
Mar 2018 — Jun 2018 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Oct 2017 — Mar 2018 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Azienda Ospedaliero Universitaria Maggiore della Carita

Data source: Azienda Ospedaliero Universitaria Maggiore della Carita

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Novara, Italy